Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants.

ABSTRACT:

Background

This study aims to assess whether Swiss guidelines for pneumococcal vaccination in children with cochlear implants are followed and whether they elicit adequate pneumococcal vaccine immunity.

Methods

We performed a retrospective analysis at the Western Switzerland University Cochlear Implants Center, reviewing data between January 2009 and December 2023. Vaccination records and serotype-specific pneumococcal IgG concentrations were extracted from computerized medical records.

Results

Fifty children were included, with a median implantation age of 1.5 years. In children <2 years old, 82% (27/33) were up to date with routine pneumococcal vaccination (3 doses of the 13-valent pneumococcal conjugate vaccine administered at 2, 4 and 12 months), yet only 56% (15/

SUBMITTER: Hominal A 

PROVIDER: S-EPMC12771958 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature